What is the latest MRF stock price?
The latest stored price for MRF is Rs 132,665.00 as of 2026-08-21.
gimli
MRF stock AI analysis
MRF Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
MRF LTD is a mid-cap stock in AUTOMOBILE. This Gimli page shows the latest available MRF price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹132,665.00
1W return
-0.62%
1M return
-1.00%
3M return
+5.23%
6M return
-9.38%
1Y return
-10.44%
Market cap
₹56,264.55 cr
PE
23.25
PB
2.68
ROE
+12.27%
ROCE
+15.43%
RSI
49.93
Turnover
₹37.29 cr
Why it can matter in screens
- Momentum: MRF is above 50DMA, below 200DMA; RSI is 49.93.
- Returns: 1D -1.00%, 1W -0.62%, 1M -1.00%, 3M +5.23%, 1Y -10.44%.
- Trend levels: 52W high ₹138,990.00, 52W low ₹122,050.00, off high -4.55%.
- Liquidity: latest turnover is ₹37.29 cr; volume vs 20D is +0.67%.
- Valuation/profitability: PE 23.25, PB 2.68, ROE +12.27%, ROCE +15.43%.
- Growth: 3Y sales CAGR +10.88%, 3Y profit CAGR +46.66%.
Quick Answers
Is MRF above its 50DMA and 200DMA?
MRF is above 50DMA, below 200DMA. The latest 50DMA is 131,966.10 and the latest 200DMA is 138,699.15.
What are MRF PE, ROE and ROCE?
MRF has PE 23.25, ROE +12.27%, and ROCE +15.43% in Gimli's latest available snapshot.
How has MRF performed recently?
MRF has returned -1.00% over 1 month, +5.23% over 3 months, and -10.44% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 8,044.22 cr | 1,457.77 cr | 702.25 cr | 1,655.80 |
| 2025-12-31 | 8,050.43 cr | 1,446.62 cr | 691.83 cr | 1,631.23 |
| 2025-09-30 | 7,378.72 cr | 1,234.00 cr | 525.64 cr | 1,239.38 |
| 2025-06-30 | 7,675.69 cr | 1,197.67 cr | 500.47 cr | 1,180.04 |
| 2025-03-31 | 7,074.82 cr | 1,189.80 cr | 510.50 cr | 1,203.68 |
| 2024-12-31 | 7,000.82 cr | 932.82 cr | n/a | nan |
| 2024-09-30 | 6,881.09 cr | 1,124.69 cr | 470.70 cr | 1,109.85 |
| 2024-06-30 | 7,196.45 cr | 1,243.66 cr | 571.02 cr | 1,346.38 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 31,149.01 cr | 5,341.97 cr | 2,426.10 cr | 5,720.39 |
| 2025-03-31 | 28,153.00 cr | 4,496.58 cr | 1,873.29 cr | 4,416.94 |
| 2024-03-31 | 25,010.81 cr | 4,569.81 cr | 2,081.23 cr | 4,907.24 |
| 2023-03-31 | 22,850.56 cr | 2,641.46 cr | 768.94 cr | 1,813.04 |
| 2022-03-31 | 19,304.43 cr | 2,362.34 cr | 647.34 cr | 1,526.34 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 31,953.51 cr | 304.59 cr | 3,206.66 cr | 20,974.75 cr |
| 2025-03-31 | 29,566.99 cr | 370.64 cr | 3,771.16 cr | 18,488.64 cr |
| 2024-03-31 | 26,849.43 cr | 303.07 cr | 2,821.50 cr | 16,703.16 cr |
| 2023-03-31 | 24,369.41 cr | 248.51 cr | 3,013.61 cr | 14,707.82 cr |
| 2022-03-31 | 23,059.74 cr | 254.39 cr | 3,228.95 cr | 14,031.90 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 4,590.30 cr | 3,156.05 cr | n/a |
| 2025-03-31 | 1,864.76 cr | 555.31 cr | n/a |
| 2024-03-31 | 3,303.36 cr | 1,139.86 cr | n/a |
| 2023-03-31 | 2,755.47 cr | -535.77 cr | n/a |
| 2022-03-31 | -578.01 cr | -2,285.02 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +27.77% | +17.42% | +12.10% | +7.08% | +42.71% | +0.09% |
| 2026-03-31 | +27.77% | +17.98% | +12.25% | +7.74% | +41.99% | +0.09% |
| 2025-12-31 | +27.73% | +18.17% | +12.51% | +8.04% | +41.59% | +0.00% |
| 2025-09-30 | +27.74% | +18.27% | +12.38% | +8.27% | +41.61% | +0.00% |
| 2025-06-30 | +27.78% | +18.67% | +11.67% | +7.70% | +41.88% | +0.00% |
| 2025-03-31 | +27.78% | +17.54% | +12.22% | +8.27% | +42.46% | +0.00% |
| 2024-12-31 | +27.80% | +18.19% | +12.00% | +8.32% | +42.01% | +0.00% |
| 2024-09-30 | +27.77% | +18.68% | +11.68% | +8.03% | +41.88% | +0.00% |
| 2024-06-30 | +27.78% | +19.08% | +10.74% | +6.84% | +42.41% | +0.00% |
| 2024-03-31 | +27.78% | +19.74% | +10.57% | +6.51% | +41.91% | +0.09% |
| 2023-12-31 | +27.75% | +19.41% | +11.46% | +7.34% | +41.38% | +0.09% |
| 2023-09-30 | +27.75% | +19.59% | +11.19% | +7.00% | +41.48% | +0.09% |
| 2023-06-30 | +27.77% | +18.77% | +11.72% | +7.28% | +41.74% | +0.09% |
| 2023-03-31 | +27.84% | +18.05% | +11.66% | +6.83% | +42.45% | +0.09% |
| 2022-12-31 | +27.87% | +18.22% | +11.37% | +6.59% | +42.53% | +0.00% |
| 2022-09-30 | +27.87% | +16.46% | +12.49% | +7.17% | +43.17% | +0.00% |
| 2022-06-30 | +27.94% | +0.00% | +28.51% | n/a | n/a | +0.00% |
| 2022-03-31 | +27.95% | +0.00% | +27.27% | n/a | n/a | +0.00% |
| 2021-12-31 | +27.90% | +0.00% | +27.49% | n/a | n/a | +0.00% |
| 2021-09-30 | +27.84% | +0.00% | +27.73% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| MARUTI | MARUTI SUZUKI INDIA LTD. | 426,487.13 cr | 29.753532 | +14.09% | -5.01% |
| M&M | MAHINDRA & MAHINDRA LTD | 409,724.11 cr | 21.839431 | +18.89% | +1.10% |
| BAJAJ-AUTO | BAJAJ AUTO LIMITED | 326,747.89 cr | 27.786102 | +31.19% | +34.72% |
| EICHERMOT | EICHER MOTORS LTD | 219,872.50 cr | 38.089517 | +24.88% | +34.06% |
| TVSMOTOR | TVS MOTOR COMPANY LTD | 208,507.48 cr | 60.175320 | +34.38% | +33.80% |
| BOSCHLTD | BOSCH LIMITED | 142,159.15 cr | 60.265018 | +16.46% | +22.10% |
| HEROMOTOCO | HERO MOTOCORP LIMITED | 114,753.28 cr | 20.898734 | +26.65% | +12.52% |
| ASHOKLEY | ASHOK LEYLAND LTD | 101,617.68 cr | 29.275945 | +20.19% | +32.05% |
Try these prompts
- Analyze MRF with valuation, momentum and industry peers
- Compare MRF with other AUTOMOBILE stocks
- Show mid-cap stocks in AUTOMOBILE above 50DMA with positive 1M return
- Find AUTOMOBILE stocks with improving momentum and reasonable valuation
Related screen ideas
- View AUTOMOBILE stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare MRF with other AUTOMOBILE stocks
Data snapshot: 2026-08-21. Not investment advice.